๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High-dose tamoxifen and sulindac effective for FAP-associated desmoid tumours

Book ID
120857825
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2004
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

High-dose tamoxifen and sulindac as firs
High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors
โœ Anika Hansmann; Claudia Adolph; Tilmann Vogel; Andreas Unger; Gabriela Moeslein ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB

## Abstract ## BACKGROUND Desmoid tumors are mesenchymal nonmetastasizing neoplasms. Although rare in the general population, they are a common extracolonic manifestation of familial adenomatous polyposis (FAP). Because of high tumor recurrence rates, surgery has been less than satisfactory in the

High-dose tamoxifen and sulindac as firs
High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors
โœ N. Julian H. Sturt; Robin K. S. Phillips; Susan K. Clark ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 67 KB

tional RCC and extensively cystic Bosniak Grade 2 or 3 disease, which may be difficult to diagnose reliably using either fine-needle or core-needle biopsy. Correlation of the results presented by Volpe et al. with the additional findings discussed in the current correspondence may be useful.